Cover Image
Market Research Report

Global Solid Tumors Drugs Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 765332
Published Content info 102 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Solid Tumors Drugs Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 102 Pages
Description

Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not cancerous). They affect bones, organs, and muscles. Based on the type of the cells, solid tumors can be carcinomas, sarcomas, and lymphomas.

During 2017, the biologics segment dominated the market and accounted for close to 55% of the market share in terms of revenue. This segment consists of medicinal products extracted from biological sources such as human, animal, microorganisms, or they are manufactured using the latest, cutting-edge biotechnological processes. Biologics include products such as enzymes, blood and blood components, gene therapy, recombinant proteins, somatic cells, tissues, and vaccines.

In terms of geography, the Americas dominated the global solid tumors drugs market. The growth of this market in the Americas is attributed to the increasing uptake of existing biologics drugs and the launch of new biologics. However, the revenue from these drugs will decrease during the forecast period because of the loss of patent exclusivity of drugs, leading to the entry of generics. This decline is expected to be partially offset by favorable reimbursement plans by the government, such as the provision of Medicare and Medicaid. The US is the largest revenue contributor in this region.

In 2018, the global Solid Tumors Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Solid Tumors Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Solid Tumors Drugs development in United States, Europe and China.

The key players covered in this study

  • Hoffmann-La Roche
  • Novartis
  • Celgene
  • Johnson & Johnson
  • Pfizer
  • BMS
  • Eli Lilly
  • GSK
  • Merck
  • Sanofi
  • AbbVie
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Boston Biomedical
  • Daiichi Sankyo

Market segment by Type, the product can be split into

  • Small Molecules
  • Biologics

Market segment by Application, split into

  • Hospitals
  • Clinics
  • Academic and Research Institutes

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Solid Tumors Drugs status, future forecast, growth opportunity, key market and key players.
  • To present the Solid Tumors Drugs development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Solid Tumors Drugs are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Solid Tumors Drugs Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Small Molecules
    • 1.4.3 Biologics
  • 1.5 Market by Application
    • 1.5.1 Global Solid Tumors Drugs Market Share by Application (2014-2025)
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Academic and Research Institutes
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Solid Tumors Drugs Market Size
  • 2.2 Solid Tumors Drugs Growth Trends by Regions
    • 2.2.1 Solid Tumors Drugs Market Size by Regions (2014-2025)
    • 2.2.2 Solid Tumors Drugs Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Solid Tumors Drugs Market Size by Manufacturers
    • 3.1.1 Global Solid Tumors Drugs Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Solid Tumors Drugs Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Solid Tumors Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2 Solid Tumors Drugs Key Players Head office and Area Served
  • 3.3 Key Players Solid Tumors Drugs Product/Solution/Service
  • 3.4 Date of Enter into Solid Tumors Drugs Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Solid Tumors Drugs Market Size by Type (2014-2019)
  • 4.2 Global Solid Tumors Drugs Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Solid Tumors Drugs Market Size (2014-2019)
  • 5.2 Solid Tumors Drugs Key Players in United States
  • 5.3 United States Solid Tumors Drugs Market Size by Type
  • 5.4 United States Solid Tumors Drugs Market Size by Application

6 Europe

  • 6.1 Europe Solid Tumors Drugs Market Size (2014-2019)
  • 6.2 Solid Tumors Drugs Key Players in Europe
  • 6.3 Europe Solid Tumors Drugs Market Size by Type
  • 6.4 Europe Solid Tumors Drugs Market Size by Application

7 China

  • 7.1 China Solid Tumors Drugs Market Size (2014-2019)
  • 7.2 Solid Tumors Drugs Key Players in China
  • 7.3 China Solid Tumors Drugs Market Size by Type
  • 7.4 China Solid Tumors Drugs Market Size by Application

8 Japan

  • 8.1 Japan Solid Tumors Drugs Market Size (2014-2019)
  • 8.2 Solid Tumors Drugs Key Players in Japan
  • 8.3 Japan Solid Tumors Drugs Market Size by Type
  • 8.4 Japan Solid Tumors Drugs Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Solid Tumors Drugs Market Size (2014-2019)
  • 9.2 Solid Tumors Drugs Key Players in Southeast Asia
  • 9.3 Southeast Asia Solid Tumors Drugs Market Size by Type
  • 9.4 Southeast Asia Solid Tumors Drugs Market Size by Application

10 India

  • 10.1 India Solid Tumors Drugs Market Size (2014-2019)
  • 10.2 Solid Tumors Drugs Key Players in India
  • 10.3 India Solid Tumors Drugs Market Size by Type
  • 10.4 India Solid Tumors Drugs Market Size by Application

11 Central & South America

  • 11.1 Central & South America Solid Tumors Drugs Market Size (2014-2019)
  • 11.2 Solid Tumors Drugs Key Players in Central & South America
  • 11.3 Central & South America Solid Tumors Drugs Market Size by Type
  • 11.4 Central & South America Solid Tumors Drugs Market Size by Application

12 International Players Profiles

  • 12.1 Hoffmann-La Roche
    • 12.1.1 Hoffmann-La Roche Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Solid Tumors Drugs Introduction
    • 12.1.4 Hoffmann-La Roche Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.1.5 Hoffmann-La Roche Recent Development
  • 12.2 Novartis
    • 12.2.1 Novartis Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Solid Tumors Drugs Introduction
    • 12.2.4 Novartis Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.2.5 Novartis Recent Development
  • 12.3 Celgene
    • 12.3.1 Celgene Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Solid Tumors Drugs Introduction
    • 12.3.4 Celgene Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.3.5 Celgene Recent Development
  • 12.4 Johnson & Johnson
    • 12.4.1 Johnson & Johnson Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Solid Tumors Drugs Introduction
    • 12.4.4 Johnson & Johnson Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.4.5 Johnson & Johnson Recent Development
  • 12.5 Pfizer
    • 12.5.1 Pfizer Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Solid Tumors Drugs Introduction
    • 12.5.4 Pfizer Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.5.5 Pfizer Recent Development
  • 12.6 BMS
    • 12.6.1 BMS Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Solid Tumors Drugs Introduction
    • 12.6.4 BMS Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.6.5 BMS Recent Development
  • 12.7 Eli Lilly
    • 12.7.1 Eli Lilly Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Solid Tumors Drugs Introduction
    • 12.7.4 Eli Lilly Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.7.5 Eli Lilly Recent Development
  • 12.8 GSK
    • 12.8.1 GSK Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Solid Tumors Drugs Introduction
    • 12.8.4 GSK Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.8.5 GSK Recent Development
  • 12.9 Merck
    • 12.9.1 Merck Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Solid Tumors Drugs Introduction
    • 12.9.4 Merck Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.9.5 Merck Recent Development
  • 12.10 Sanofi
    • 12.10.1 Sanofi Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Solid Tumors Drugs Introduction
    • 12.10.4 Sanofi Revenue in Solid Tumors Drugs Business (2014-2019)
    • 12.10.5 Sanofi Recent Development
  • 12.11 AbbVie
  • 12.12 AstraZeneca
  • 12.13 Bayer
  • 12.14 Biogen
  • 12.15 Boehringer Ingelheim
  • 12.16 Boston Biomedical
  • 12.17 Daiichi Sankyo

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Solid Tumors Drugs Key Market Segments
  • Table Key Players Solid Tumors Drugs Covered
  • Table Global Solid Tumors Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Solid Tumors Drugs Market Size Market Share by Type 2014-2025
  • Figure Small Molecules Figures
  • Table Key Players of Small Molecules
  • Figure Biologics Figures
  • Table Key Players of Biologics
  • Table Global Solid Tumors Drugs Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospitals Case Studies
  • Figure Clinics Case Studies
  • Figure Academic and Research Institutes Case Studies
  • Figure Solid Tumors Drugs Report Years Considered
  • Table Global Solid Tumors Drugs Market Size 2014-2025 (Million US$)
  • Figure Global Solid Tumors Drugs Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Solid Tumors Drugs Market Size by Regions 2014-2025 (Million US$)
  • Table Global Solid Tumors Drugs Market Size by Regions 2014-2019 (Million US$)
  • Table Global Solid Tumors Drugs Market Share by Regions 2014-2019
  • Figure Global Solid Tumors Drugs Market Share by Regions 2014-2019
  • Figure Global Solid Tumors Drugs Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Solid Tumors Drugs Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Solid Tumors Drugs Market Share by Manufacturers (2014-2019)
  • Figure Global Solid Tumors Drugs Market Share by Manufacturers in 2018
  • Table Global Solid Tumors Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Solid Tumors Drugs Product/Solution/Service
  • Table Date of Enter into Solid Tumors Drugs Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table Global Solid Tumors Drugs Market Size Share by Type (2014-2019)
  • Figure Global Solid Tumors Drugs Market Size Market Share by Type (2014-2019)
  • Table Global Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table Global Solid Tumors Drugs Market Size Share by Application (2014-2019)
  • Figure Global Solid Tumors Drugs Market Size Market Share by Application (2014-2019)
  • Figure Global Solid Tumors Drugs Revenue Market Share by Application in 2018
  • Figure United States Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table United States Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table United States Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table United States Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table United States Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table United States Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table United States Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure Europe Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table Europe Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table Europe Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table Europe Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table Europe Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure China Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table China Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table China Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table China Solid Tumors Drugs Market Size by Type (2014-20189) (Million US$)
  • Table China Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table China Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table China Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure Japan Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table Japan Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table Japan Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table Japan Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table Japan Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure Southeast Asia Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table Southeast Asia Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table Southeast Asia Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure India Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table India Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table India Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table India Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table India Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table India Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table India Solid Tumors Drugs Market Share by Application (2014-2019)
  • Figure Central & South America Solid Tumors Drugs Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Solid Tumors Drugs Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Solid Tumors Drugs Market Share (2018-2019)
  • Table Central & South America Solid Tumors Drugs Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Solid Tumors Drugs Market Share by Type (2014-2019)
  • Table Central & South America Solid Tumors Drugs Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Solid Tumors Drugs Market Share by Application (2014-2019)
  • Table Hoffmann-La Roche Company Details
  • Table Hoffmann-La Roche Revenue in Solid Tumors Drugs Business (2014-2019) (Million US$)
  • Figure Hoffmann-La Roche Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Hoffmann-La Roche Recent Development
  • Table Novartis Company Details
  • Table Novartis Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Novartis Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Novartis Recent Development
  • Table Celgene Company Details
  • Table Celgene Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Celgene Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Celgene Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Pfizer Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Pfizer Recent Development
  • Table BMS Company Details
  • Table BMS Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure BMS Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table BMS Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Eli Lilly Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Eli Lilly Recent Development
  • Table GSK Company Details
  • Table GSK Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure GSK Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table GSK Recent Development
  • Table Merck Company Details
  • Table Merck Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Merck Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Merck Recent Development
  • Table Sanofi Company Details
  • Table Sanofi Revenue in Solid Tumors Drugs Business (2014-2019)(Million US$)
  • Figure Sanofi Revenue Growth Rate in Solid Tumors Drugs Business (2014-2019)
  • Table Sanofi Recent Development
  • Table AbbVie Company Details
  • Table AstraZeneca Company Details
  • Table Bayer Company Details
  • Table Biogen Company Details
  • Table Boehringer Ingelheim Company Details
  • Table Boston Biomedical Company Details
  • Table Daiichi Sankyo Company Details
  • Table Global Solid Tumors Drugs Market Size by Regions (Million US$) 2019-2025
  • Figure Global Solid Tumors Drugs Market Size Share by Regions (2019-2025)
  • Figure Global Solid Tumors Drugs Market Size Share by Regions in 2025
  • Figure United States Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure China Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure India Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Solid Tumors Drugs Market Size Forecast (2019-2025)(Million USD)
  • Table Global Solid Tumors Drugs Market Size by Product (2019-2025) (Million US$)
  • Figure Global Solid Tumors Drugs Market Size by Product (2019-2025)
  • Figure Global Solid Tumors Drugs Market Size by Product in 2025
  • Table Global Solid Tumors Drugs Market Size by Application (2019-2025) (Million US$)
  • Figure Global Solid Tumors Drugs Market Size by Application (2019-2025)
  • Figure Global Solid Tumors Drugs Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top